

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.22337762 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.76115921 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.76115921 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.07537189 |
| 5 | respiratory electron transport chain (GO:0022904) | 4.93408123 |
| 6 | electron transport chain (GO:0022900) | 4.88067604 |
| 7 | response to pheromone (GO:0019236) | 4.42220175 |
| 8 | protein complex biogenesis (GO:0070271) | 4.33218814 |
| 9 | oxidative phosphorylation (GO:0006119) | 4.23527544 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.22240901 |
| 11 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.19861892 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 4.19861892 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.19861892 |
| 14 | chaperone-mediated protein transport (GO:0072321) | 4.01664428 |
| 15 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.01592981 |
| 16 | cullin deneddylation (GO:0010388) | 3.90243294 |
| 17 | tricarboxylic acid cycle (GO:0006099) | 3.86948802 |
| 18 | synaptic transmission, dopaminergic (GO:0001963) | 3.85147272 |
| 19 | vocalization behavior (GO:0071625) | 3.70590239 |
| 20 | nucleoside transmembrane transport (GO:1901642) | 3.68228495 |
| 21 | GDP-mannose metabolic process (GO:0019673) | 3.67715871 |
| 22 | dopamine transport (GO:0015872) | 3.66548510 |
| 23 | regulation of hexokinase activity (GO:1903299) | 3.62238606 |
| 24 | regulation of glucokinase activity (GO:0033131) | 3.62238606 |
| 25 | axoneme assembly (GO:0035082) | 3.60594124 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 3.59882988 |
| 27 | regulation of relaxation of muscle (GO:1901077) | 3.59161574 |
| 28 | succinate metabolic process (GO:0006105) | 3.49227007 |
| 29 | striatum development (GO:0021756) | 3.45907643 |
| 30 | protein localization to synapse (GO:0035418) | 3.44037642 |
| 31 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.39837863 |
| 32 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.35706587 |
| 33 | short-chain fatty acid metabolic process (GO:0046459) | 3.34115657 |
| 34 | ATP biosynthetic process (GO:0006754) | 3.34081911 |
| 35 | nonmotile primary cilium assembly (GO:0035058) | 3.32313124 |
| 36 | inositol phosphate catabolic process (GO:0071545) | 3.30435163 |
| 37 | mannose metabolic process (GO:0006013) | 3.29335215 |
| 38 | protein localization to cilium (GO:0061512) | 3.28414995 |
| 39 | regulation of protein kinase A signaling (GO:0010738) | 3.27961625 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.26081323 |
| 41 | protein deneddylation (GO:0000338) | 3.25995738 |
| 42 | glutamate secretion (GO:0014047) | 3.25605243 |
| 43 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.24422109 |
| 44 | negative regulation of microtubule polymerization (GO:0031115) | 3.24325043 |
| 45 | regulation of mitochondrial translation (GO:0070129) | 3.22222776 |
| 46 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.19329804 |
| 47 | catecholamine transport (GO:0051937) | 3.17956761 |
| 48 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.15910722 |
| 49 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.15182967 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 3.13508263 |
| 51 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.13202556 |
| 52 | behavioral response to cocaine (GO:0048148) | 3.12647289 |
| 53 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.11074504 |
| 54 | establishment of integrated proviral latency (GO:0075713) | 3.10506996 |
| 55 | hydrogen ion transmembrane transport (GO:1902600) | 3.10445513 |
| 56 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.06055165 |
| 57 | inositol phosphate dephosphorylation (GO:0046855) | 3.03445494 |
| 58 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.03445494 |
| 59 | mating behavior (GO:0007617) | 3.03024394 |
| 60 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.02339383 |
| 61 | regulation of cofactor metabolic process (GO:0051193) | 3.01597777 |
| 62 | regulation of coenzyme metabolic process (GO:0051196) | 3.01597777 |
| 63 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.00329281 |
| 64 | neurotransmitter secretion (GO:0007269) | 2.99547918 |
| 65 | respiratory chain complex IV assembly (GO:0008535) | 2.99241383 |
| 66 | inner mitochondrial membrane organization (GO:0007007) | 2.98702127 |
| 67 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.98593824 |
| 68 | protein neddylation (GO:0045116) | 2.98181455 |
| 69 | regulation of synapse structural plasticity (GO:0051823) | 2.98121349 |
| 70 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.97370091 |
| 71 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.97370091 |
| 72 | brain morphogenesis (GO:0048854) | 2.97355267 |
| 73 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.97186915 |
| 74 | neurotransmitter catabolic process (GO:0042135) | 2.96960872 |
| 75 | peroxisome fission (GO:0016559) | 2.95324065 |
| 76 | regulation of cilium movement (GO:0003352) | 2.94203770 |
| 77 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.93641250 |
| 78 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.93641250 |
| 79 | regulation of neurotransmitter uptake (GO:0051580) | 2.91272500 |
| 80 | regulation of cell communication by electrical coupling (GO:0010649) | 2.91192881 |
| 81 | glycerophospholipid catabolic process (GO:0046475) | 2.91140916 |
| 82 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89881193 |
| 83 | NADH metabolic process (GO:0006734) | 2.89537006 |
| 84 | neuron-neuron synaptic transmission (GO:0007270) | 2.89453729 |
| 85 | negative regulation of dendrite development (GO:2000171) | 2.88571198 |
| 86 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.88360365 |
| 87 | cilium morphogenesis (GO:0060271) | 2.87698622 |
| 88 | behavioral response to ethanol (GO:0048149) | 2.87440403 |
| 89 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86398525 |
| 90 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.85570308 |
| 91 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.85387078 |
| 92 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.82812562 |
| 93 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.82285908 |
| 94 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.81893782 |
| 95 | ketone body metabolic process (GO:1902224) | 2.81329332 |
| 96 | cytochrome complex assembly (GO:0017004) | 2.81210962 |
| 97 | regulation of synaptic vesicle transport (GO:1902803) | 2.80548325 |
| 98 | histone H2A acetylation (GO:0043968) | 2.75354779 |
| 99 | cofactor transport (GO:0051181) | 2.74305182 |
| 100 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.72594987 |
| 101 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.72061667 |
| 102 | maternal behavior (GO:0042711) | 2.71860812 |
| 103 | proton transport (GO:0015992) | 2.71715646 |
| 104 | nephron tubule morphogenesis (GO:0072078) | 2.71622543 |
| 105 | nephron epithelium morphogenesis (GO:0072088) | 2.71622543 |
| 106 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.70697587 |
| 107 | regulation of oxidative phosphorylation (GO:0002082) | 2.69897566 |
| 108 | presynaptic membrane assembly (GO:0097105) | 2.69505994 |
| 109 | nucleoside transport (GO:0015858) | 2.68672691 |
| 110 | behavioral response to nicotine (GO:0035095) | 2.68146341 |
| 111 | neuron recognition (GO:0008038) | 2.66965232 |
| 112 | endocrine pancreas development (GO:0031018) | 2.66943751 |
| 113 | sphingomyelin metabolic process (GO:0006684) | 2.66322038 |
| 114 | hydrogen transport (GO:0006818) | 2.66303550 |
| 115 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.64903168 |
| 116 | oxaloacetate metabolic process (GO:0006107) | 2.63892510 |
| 117 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.63524360 |
| 118 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.63469320 |
| 119 | detection of calcium ion (GO:0005513) | 2.63415074 |
| 120 | urinary tract smooth muscle contraction (GO:0014848) | 2.61552699 |
| 121 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.61395673 |
| 122 | aerobic respiration (GO:0009060) | 2.59336351 |
| 123 | establishment of viral latency (GO:0019043) | 2.59059585 |
| 124 | otic vesicle formation (GO:0030916) | 2.57993648 |
| 125 | regulation of catecholamine metabolic process (GO:0042069) | 2.56188421 |
| 126 | regulation of dopamine metabolic process (GO:0042053) | 2.56188421 |
| 127 | cellular response to leptin stimulus (GO:0044320) | 2.56105656 |
| 128 | artery smooth muscle contraction (GO:0014824) | 2.56067891 |
| 129 | prepulse inhibition (GO:0060134) | 2.55042273 |
| 130 | postsynaptic membrane organization (GO:0001941) | 2.54965371 |
| 131 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.54906813 |
| 132 | neuromuscular synaptic transmission (GO:0007274) | 2.54533715 |
| 133 | response to histamine (GO:0034776) | 2.54378911 |
| 134 | photoreceptor cell maintenance (GO:0045494) | 2.54348604 |
| 135 | positive regulation of glycolytic process (GO:0045821) | 2.53765193 |
| 136 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.53362981 |
| 137 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.52914071 |
| 138 | regulation of action potential (GO:0098900) | 2.51851463 |
| 139 | positive regulation of synapse assembly (GO:0051965) | 2.51655171 |
| 140 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.50697186 |
| 141 | ribonucleoprotein complex disassembly (GO:0032988) | 2.50092417 |
| 142 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.49832083 |
| 143 | dopamine biosynthetic process (GO:0042416) | 2.49372168 |
| 144 | intraciliary transport (GO:0042073) | 2.49317943 |
| 145 | GTP biosynthetic process (GO:0006183) | 2.49036665 |
| 146 | hindbrain development (GO:0030902) | 2.48101604 |
| 147 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.47707249 |
| 148 | protein prenylation (GO:0018342) | 2.46395961 |
| 149 | prenylation (GO:0097354) | 2.46395961 |
| 150 | phospholipid catabolic process (GO:0009395) | 2.44954512 |
| 151 | branched-chain amino acid catabolic process (GO:0009083) | 2.43633021 |
| 152 | cilium organization (GO:0044782) | 2.43408392 |
| 153 | glycosphingolipid biosynthetic process (GO:0006688) | 2.42123476 |
| 154 | cilium assembly (GO:0042384) | 2.41807708 |
| 155 | establishment of protein localization to peroxisome (GO:0072663) | 2.40882271 |
| 156 | protein localization to peroxisome (GO:0072662) | 2.40882271 |
| 157 | protein targeting to peroxisome (GO:0006625) | 2.40882271 |
| 158 | protein polyglutamylation (GO:0018095) | 2.40736083 |
| 159 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.40631841 |
| 160 | cornea development in camera-type eye (GO:0061303) | 2.40217258 |
| 161 | polyol catabolic process (GO:0046174) | 2.39962696 |
| 162 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.39716185 |
| 163 | protein K11-linked deubiquitination (GO:0035871) | 2.36250170 |
| 164 | nucleobase catabolic process (GO:0046113) | 2.36167204 |
| 165 | coenzyme A biosynthetic process (GO:0015937) | 2.36159786 |
| 166 | ubiquinone biosynthetic process (GO:0006744) | 2.35812020 |
| 167 | ubiquinone metabolic process (GO:0006743) | 2.35349450 |
| 168 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.32935974 |
| 169 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.32935974 |
| 170 | auditory receptor cell differentiation (GO:0042491) | 2.32014075 |
| 171 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.31603983 |
| 172 | insulin secretion (GO:0030073) | 2.30286399 |
| 173 | cardiac conduction (GO:0061337) | 2.28694576 |
| 174 | peroxisome organization (GO:0007031) | 2.28215602 |
| 175 | coenzyme A metabolic process (GO:0015936) | 2.27690134 |
| 176 | protein localization to Golgi apparatus (GO:0034067) | 2.25967957 |
| 177 | vascular smooth muscle contraction (GO:0014829) | 2.25895918 |
| 178 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.24390314 |
| 179 | negative regulation of appetite (GO:0032099) | 2.24016511 |
| 180 | negative regulation of response to food (GO:0032096) | 2.24016511 |
| 181 | melanosome transport (GO:0032402) | 2.22534417 |
| 182 | retinal ganglion cell axon guidance (GO:0031290) | 2.22505331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.14832409 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89049424 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.19624985 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.04636146 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.58670889 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.56811763 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.56302042 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.35071452 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.32209216 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.23881210 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.18608418 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.16637099 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.15389710 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.06016073 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.01402734 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98473945 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98272055 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98026046 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95694270 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95348570 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.95275551 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.93613831 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.90088628 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.88070483 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.84860271 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.81393977 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81025643 |
| 28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80872499 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74589949 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73194790 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71981891 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.70550142 |
| 33 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.69128454 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.68631100 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65928669 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65928669 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.65924999 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64837087 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63131495 |
| 40 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.61825734 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56185226 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56127843 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55289605 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54445954 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53563794 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49319772 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49179172 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47863557 |
| 49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46341557 |
| 50 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.46095314 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45831527 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45667960 |
| 53 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.43846274 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43815476 |
| 55 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.42617890 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41652466 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38328067 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38191820 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37496544 |
| 60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36499961 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.34541981 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.34399664 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34081517 |
| 64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.33251594 |
| 65 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.32761837 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32260326 |
| 67 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.31775465 |
| 68 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31042318 |
| 69 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30542234 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.28702956 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27582047 |
| 72 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27143768 |
| 73 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.26977849 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26674817 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.26087213 |
| 76 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24777274 |
| 77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24111866 |
| 78 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24099823 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23747025 |
| 80 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23332981 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22894935 |
| 82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22555236 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22268949 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21186656 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20943480 |
| 86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20760363 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20254682 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19807851 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18952053 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18614374 |
| 91 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.18547994 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17920115 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17655464 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16997606 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16816382 |
| 96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14425333 |
| 97 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14234003 |
| 98 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.13416311 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12571994 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12571994 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12406185 |
| 102 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11209640 |
| 103 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10186766 |
| 104 | JUN_21703547_ChIP-Seq_K562_Human | 1.09975385 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.09718697 |
| 106 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.09392218 |
| 107 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08954948 |
| 108 | TBL1_22424771_ChIP-Seq_293T_Human | 1.08206124 |
| 109 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08018958 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07469920 |
| 111 | NFYB_21822215_ChIP-Seq_K562_Human | 1.06435578 |
| 112 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06088854 |
| 113 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06002736 |
| 114 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05732328 |
| 115 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05732328 |
| 116 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05581582 |
| 117 | NFYA_21822215_ChIP-Seq_K562_Human | 1.05418052 |
| 118 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04682977 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04443840 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04051964 |
| 121 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03667791 |
| 122 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02474708 |
| 123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01187974 |
| 124 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00568745 |
| 125 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00085800 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99939901 |
| 127 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98741488 |
| 128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98602992 |
| 129 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98602992 |
| 130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97385374 |
| 131 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95987049 |
| 132 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95067668 |
| 133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94579799 |
| 134 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94563328 |
| 135 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94562427 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94417960 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94417519 |
| 138 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94381038 |
| 139 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93255326 |
| 140 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93102838 |
| 141 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93102838 |
| 142 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.92598184 |
| 143 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92586630 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90522802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.07074861 |
| 2 | MP0002822_catalepsy | 3.81983006 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.28606122 |
| 4 | MP0001529_abnormal_vocalization | 2.75056731 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.73779907 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.65756399 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.55393794 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.53370147 |
| 9 | MP0004270_analgesia | 2.51808197 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.50713336 |
| 11 | MP0009745_abnormal_behavioral_response | 2.49666817 |
| 12 | MP0002736_abnormal_nociception_after | 2.37966005 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.30465079 |
| 14 | MP0003195_calcinosis | 2.27981745 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.22915387 |
| 16 | MP0003122_maternal_imprinting | 2.21743713 |
| 17 | MP0004043_abnormal_pH_regulation | 2.21363440 |
| 18 | MP0002064_seizures | 2.20218823 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.17029069 |
| 20 | MP0002272_abnormal_nervous_system | 2.16332596 |
| 21 | MP0000751_myopathy | 2.15923567 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.12786539 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.12785122 |
| 24 | MP0003646_muscle_fatigue | 2.09936389 |
| 25 | MP0001905_abnormal_dopamine_level | 2.06009439 |
| 26 | MP0001984_abnormal_olfaction | 2.03209946 |
| 27 | MP0002184_abnormal_innervation | 2.01968379 |
| 28 | MP0001440_abnormal_grooming_behavior | 1.93689563 |
| 29 | MP0005253_abnormal_eye_physiology | 1.90135530 |
| 30 | MP0009046_muscle_twitch | 1.85879215 |
| 31 | MP0004142_abnormal_muscle_tone | 1.79339298 |
| 32 | MP0005379_endocrine/exocrine_gland_phen | 1.77137278 |
| 33 | MP0002254_reproductive_system_inflammat | 1.76326549 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.74166634 |
| 35 | MP0001944_abnormal_pancreas_morphology | 1.73338424 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.72563613 |
| 37 | MP0001188_hyperpigmentation | 1.71572834 |
| 38 | MP0000749_muscle_degeneration | 1.71543044 |
| 39 | MP0000778_abnormal_nervous_system | 1.70667683 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.69823210 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.69660265 |
| 42 | MP0005499_abnormal_olfactory_system | 1.69269623 |
| 43 | MP0005394_taste/olfaction_phenotype | 1.69269623 |
| 44 | MP0008789_abnormal_olfactory_epithelium | 1.68160089 |
| 45 | MP0004147_increased_porphyrin_level | 1.66165653 |
| 46 | MP0005646_abnormal_pituitary_gland | 1.60792251 |
| 47 | MP0001486_abnormal_startle_reflex | 1.58577570 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.57140704 |
| 49 | MP0002163_abnormal_gland_morphology | 1.56143220 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.55876372 |
| 51 | MP0004924_abnormal_behavior | 1.55876372 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.55129248 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.52022695 |
| 54 | MP0000569_abnormal_digit_pigmentation | 1.50838332 |
| 55 | MP0002557_abnormal_social/conspecific_i | 1.50537185 |
| 56 | MP0004085_abnormal_heartbeat | 1.49732526 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.48348440 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.47440722 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.42471619 |
| 60 | MP0001970_abnormal_pain_threshold | 1.42422650 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.42352392 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.41526343 |
| 63 | MP0002971_abnormal_brown_adipose | 1.30440715 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.28816912 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 1.28529480 |
| 66 | MP0002090_abnormal_vision | 1.28227132 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 1.25514238 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 1.23911978 |
| 69 | MP0000955_abnormal_spinal_cord | 1.23379482 |
| 70 | MP0004885_abnormal_endolymph | 1.22903881 |
| 71 | MP0000631_abnormal_neuroendocrine_gland | 1.22865617 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.22313563 |
| 73 | MP0008569_lethality_at_weaning | 1.21256969 |
| 74 | MP0004811_abnormal_neuron_physiology | 1.19420641 |
| 75 | MP0002751_abnormal_autonomic_nervous | 1.18915211 |
| 76 | MP0006072_abnormal_retinal_apoptosis | 1.18189905 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.17871749 |
| 78 | MP0003787_abnormal_imprinting | 1.17573604 |
| 79 | MP0003121_genomic_imprinting | 1.16508599 |
| 80 | MP0002938_white_spotting | 1.16105051 |
| 81 | MP0002909_abnormal_adrenal_gland | 1.15902838 |
| 82 | MP0004484_altered_response_of | 1.14278337 |
| 83 | MP0000372_irregular_coat_pigmentation | 1.12948636 |
| 84 | MP0005332_abnormal_amino_acid | 1.12697816 |
| 85 | MP0004233_abnormal_muscle_weight | 1.12413237 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 1.10921212 |
| 87 | MP0002693_abnormal_pancreas_physiology | 1.10801323 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.09414111 |
| 89 | MP0002882_abnormal_neuron_morphology | 1.08847354 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.07666937 |
| 91 | MP0001986_abnormal_taste_sensitivity | 1.05195282 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 1.01818354 |
| 93 | MP0000747_muscle_weakness | 0.98342054 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.98025057 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.97548950 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.97495397 |
| 97 | MP0006138_congestive_heart_failure | 0.97461642 |
| 98 | MP0003186_abnormal_redox_activity | 0.97390621 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.96559977 |
| 100 | MP0000427_abnormal_hair_cycle | 0.95435867 |
| 101 | MP0005620_abnormal_muscle_contractility | 0.94164033 |
| 102 | MP0009697_abnormal_copulation | 0.92549905 |
| 103 | MP0002152_abnormal_brain_morphology | 0.91869093 |
| 104 | MP0002752_abnormal_somatic_nervous | 0.91571443 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.91379785 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.91195742 |
| 107 | MP0008877_abnormal_DNA_methylation | 0.90480957 |
| 108 | MP0001764_abnormal_homeostasis | 0.89176513 |
| 109 | MP0005448_abnormal_energy_balance | 0.88720762 |
| 110 | MP0002102_abnormal_ear_morphology | 0.88446614 |
| 111 | MP0002928_abnormal_bile_duct | 0.86703535 |
| 112 | MP0005535_abnormal_body_temperature | 0.86133007 |
| 113 | MP0005551_abnormal_eye_electrophysiolog | 0.84828308 |
| 114 | MP0003136_yellow_coat_color | 0.83974372 |
| 115 | MP0003937_abnormal_limbs/digits/tail_de | 0.83813813 |
| 116 | MP0001756_abnormal_urination | 0.83490834 |
| 117 | MP0008775_abnormal_heart_ventricle | 0.83057171 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.81642839 |
| 119 | MP0003879_abnormal_hair_cell | 0.80446576 |
| 120 | MP0003953_abnormal_hormone_level | 0.79251922 |
| 121 | MP0005195_abnormal_posterior_eye | 0.79197761 |
| 122 | MP0002106_abnormal_muscle_physiology | 0.78845860 |
| 123 | MP0005330_cardiomyopathy | 0.75411417 |
| 124 | MP0003315_abnormal_perineum_morphology | 0.75125324 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.74555595 |
| 126 | MP0005369_muscle_phenotype | 0.73658395 |
| 127 | MP0004742_abnormal_vestibular_system | 0.73452260 |
| 128 | MP0002160_abnormal_reproductive_system | 0.73360566 |
| 129 | MP0001664_abnormal_digestion | 0.72583484 |
| 130 | MP0002229_neurodegeneration | 0.72218228 |
| 131 | MP0004133_heterotaxia | 0.70536424 |
| 132 | MP0008872_abnormal_physiological_respon | 0.69794251 |
| 133 | MP0002269_muscular_atrophy | 0.68926156 |
| 134 | MP0003123_paternal_imprinting | 0.68713872 |
| 135 | MP0000759_abnormal_skeletal_muscle | 0.66984051 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.66876132 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.66363936 |
| 138 | MP0002233_abnormal_nose_morphology | 0.64975282 |
| 139 | MP0005084_abnormal_gallbladder_morpholo | 0.63649166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.80171653 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.51994627 |
| 3 | Progressive macrocephaly (HP:0004481) | 4.91393499 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.83119153 |
| 5 | Acute encephalopathy (HP:0006846) | 4.54039447 |
| 6 | Neuroendocrine neoplasm (HP:0100634) | 4.44707922 |
| 7 | Pheochromocytoma (HP:0002666) | 4.34106778 |
| 8 | Increased CSF lactate (HP:0002490) | 4.22741748 |
| 9 | Increased serum pyruvate (HP:0003542) | 4.09858161 |
| 10 | Abnormality of glycolysis (HP:0004366) | 4.09858161 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.92129347 |
| 12 | Hypothermia (HP:0002045) | 3.78317892 |
| 13 | Focal motor seizures (HP:0011153) | 3.73143312 |
| 14 | Global brain atrophy (HP:0002283) | 3.54025335 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.48188914 |
| 16 | Pancreatic fibrosis (HP:0100732) | 3.47369285 |
| 17 | Methylmalonic acidemia (HP:0002912) | 3.44734719 |
| 18 | Intestinal atresia (HP:0011100) | 3.43135110 |
| 19 | Hepatic necrosis (HP:0002605) | 3.39172264 |
| 20 | Hyperglycinemia (HP:0002154) | 3.39168943 |
| 21 | Tubulointerstitial nephritis (HP:0001970) | 3.36373710 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 3.36321174 |
| 23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.31957594 |
| 24 | Febrile seizures (HP:0002373) | 3.28579539 |
| 25 | Exercise intolerance (HP:0003546) | 3.23135774 |
| 26 | Pancreatic cysts (HP:0001737) | 3.22210248 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 3.11641035 |
| 28 | Cerebral edema (HP:0002181) | 3.07171464 |
| 29 | Atonic seizures (HP:0010819) | 3.05900340 |
| 30 | Central scotoma (HP:0000603) | 3.05362319 |
| 31 | Limb dystonia (HP:0002451) | 3.00731444 |
| 32 | Akinesia (HP:0002304) | 3.00450036 |
| 33 | Ketoacidosis (HP:0001993) | 2.97084931 |
| 34 | Optic disc pallor (HP:0000543) | 2.94734056 |
| 35 | Epileptic encephalopathy (HP:0200134) | 2.90412710 |
| 36 | Dyskinesia (HP:0100660) | 2.90166048 |
| 37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.88668330 |
| 38 | Abnormality of vitamin B metabolism (HP:0004340) | 2.88465087 |
| 39 | Myokymia (HP:0002411) | 2.84949170 |
| 40 | Abnormality of midbrain morphology (HP:0002418) | 2.79598185 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.79598185 |
| 42 | Poor suck (HP:0002033) | 2.78500946 |
| 43 | Lactic acidosis (HP:0003128) | 2.78369351 |
| 44 | Leukodystrophy (HP:0002415) | 2.78188972 |
| 45 | Focal seizures (HP:0007359) | 2.77356670 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.75616643 |
| 47 | Hyperalaninemia (HP:0003348) | 2.75616643 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.75616643 |
| 49 | True hermaphroditism (HP:0010459) | 2.75295597 |
| 50 | Hyperventilation (HP:0002883) | 2.72284100 |
| 51 | Diminished movement (HP:0002374) | 2.72167820 |
| 52 | Progressive inability to walk (HP:0002505) | 2.70836105 |
| 53 | Respiratory failure (HP:0002878) | 2.70678273 |
| 54 | Glycosuria (HP:0003076) | 2.63468404 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 2.63468404 |
| 56 | Nephronophthisis (HP:0000090) | 2.63282633 |
| 57 | Abnormal hair whorl (HP:0010721) | 2.61530373 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.60663875 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 2.60658904 |
| 60 | Double outlet right ventricle (HP:0001719) | 2.58126494 |
| 61 | Congenital malformation of the right heart (HP:0011723) | 2.58126494 |
| 62 | Gait imbalance (HP:0002141) | 2.55156311 |
| 63 | Prolonged QT interval (HP:0001657) | 2.54895226 |
| 64 | Poor coordination (HP:0002370) | 2.50107949 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42001402 |
| 66 | Agitation (HP:0000713) | 2.40842515 |
| 67 | Exercise-induced muscle cramps (HP:0003710) | 2.40816840 |
| 68 | Increased serum lactate (HP:0002151) | 2.37546365 |
| 69 | Methylmalonic aciduria (HP:0012120) | 2.36686191 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.35953524 |
| 71 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.34337068 |
| 72 | Abnormality of the renal medulla (HP:0100957) | 2.34049658 |
| 73 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.33812016 |
| 74 | Type II lissencephaly (HP:0007260) | 2.32512306 |
| 75 | Abnormality of macular pigmentation (HP:0008002) | 2.31729245 |
| 76 | Acanthocytosis (HP:0001927) | 2.31643005 |
| 77 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.30653866 |
| 78 | Respiratory difficulties (HP:0002880) | 2.30224172 |
| 79 | Decreased muscle mass (HP:0003199) | 2.29871015 |
| 80 | Severe visual impairment (HP:0001141) | 2.29850366 |
| 81 | Abnormality of the renal cortex (HP:0011035) | 2.29574638 |
| 82 | Postural tremor (HP:0002174) | 2.28605778 |
| 83 | Polyphagia (HP:0002591) | 2.28324595 |
| 84 | Nephrogenic diabetes insipidus (HP:0009806) | 2.27730683 |
| 85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23571204 |
| 86 | Absence seizures (HP:0002121) | 2.23357902 |
| 87 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.20858762 |
| 88 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.20858762 |
| 89 | Exercise-induced myalgia (HP:0003738) | 2.20759554 |
| 90 | Retinal dysplasia (HP:0007973) | 2.18738191 |
| 91 | Abnormality of the vocal cords (HP:0008777) | 2.18579686 |
| 92 | Shoulder girdle muscle weakness (HP:0003547) | 2.18056631 |
| 93 | Abnormality of the calf musculature (HP:0001430) | 2.17341965 |
| 94 | Rimmed vacuoles (HP:0003805) | 2.17322123 |
| 95 | Abnormality of glycine metabolism (HP:0010895) | 2.16562847 |
| 96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.16562847 |
| 97 | Hypoglycemic coma (HP:0001325) | 2.16067411 |
| 98 | X-linked dominant inheritance (HP:0001423) | 2.14136428 |
| 99 | Broad-based gait (HP:0002136) | 2.12853448 |
| 100 | Polydipsia (HP:0001959) | 2.12154130 |
| 101 | Abnormal drinking behavior (HP:0030082) | 2.12154130 |
| 102 | Renal cortical cysts (HP:0000803) | 2.11840525 |
| 103 | Emotional lability (HP:0000712) | 2.11139066 |
| 104 | Amblyopia (HP:0000646) | 2.09923133 |
| 105 | Anxiety (HP:0000739) | 2.09299459 |
| 106 | Abnormality of vitamin metabolism (HP:0100508) | 2.09293622 |
| 107 | Fetal akinesia sequence (HP:0001989) | 2.09172582 |
| 108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06663287 |
| 109 | Palpitations (HP:0001962) | 2.06031896 |
| 110 | Hemiparesis (HP:0001269) | 2.05249248 |
| 111 | Gaze-evoked nystagmus (HP:0000640) | 2.05074221 |
| 112 | Ketosis (HP:0001946) | 2.04891408 |
| 113 | Visual hallucinations (HP:0002367) | 2.04802635 |
| 114 | Oligomenorrhea (HP:0000876) | 2.04314025 |
| 115 | Increased muscle lipid content (HP:0009058) | 2.01366270 |
| 116 | Inability to walk (HP:0002540) | 2.00594920 |
| 117 | Dialeptic seizures (HP:0011146) | 2.00231016 |
| 118 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.98410016 |
| 119 | Tubular atrophy (HP:0000092) | 1.97813460 |
| 120 | Tubulointerstitial abnormality (HP:0001969) | 1.97254577 |
| 121 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.96440599 |
| 122 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.96440599 |
| 123 | Hyperglycemia (HP:0003074) | 1.96434623 |
| 124 | Delayed gross motor development (HP:0002194) | 1.95369081 |
| 125 | Genital tract atresia (HP:0001827) | 1.95351867 |
| 126 | Atrial fibrillation (HP:0005110) | 1.95071368 |
| 127 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.94736226 |
| 128 | Cystic liver disease (HP:0006706) | 1.94692882 |
| 129 | Failure to thrive in infancy (HP:0001531) | 1.94414406 |
| 130 | Primary atrial arrhythmia (HP:0001692) | 1.93920951 |
| 131 | Hypoplasia of the uterus (HP:0000013) | 1.93130037 |
| 132 | Left ventricular hypertrophy (HP:0001712) | 1.92193093 |
| 133 | Hypoglycemic seizures (HP:0002173) | 1.91883486 |
| 134 | Generalized tonic-clonic seizures (HP:0002069) | 1.91806350 |
| 135 | Cerebral hemorrhage (HP:0001342) | 1.91494241 |
| 136 | Supraventricular tachycardia (HP:0004755) | 1.90102378 |
| 137 | Delayed CNS myelination (HP:0002188) | 1.89394554 |
| 138 | Progressive cerebellar ataxia (HP:0002073) | 1.88466240 |
| 139 | Sudden death (HP:0001699) | 1.88353904 |
| 140 | Hypoventilation (HP:0002791) | 1.88350688 |
| 141 | Abnormality of renal resorption (HP:0011038) | 1.88167352 |
| 142 | Gastrointestinal atresia (HP:0002589) | 1.87575983 |
| 143 | Vaginal atresia (HP:0000148) | 1.87189516 |
| 144 | Pelvic girdle muscle weakness (HP:0003749) | 1.86499393 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85733491 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85316414 |
| 147 | Postaxial foot polydactyly (HP:0001830) | 1.83935853 |
| 148 | Metaphyseal dysplasia (HP:0100255) | 1.83911326 |
| 149 | Dysdiadochokinesis (HP:0002075) | 1.83608204 |
| 150 | Specific learning disability (HP:0001328) | 1.83141975 |
| 151 | Hypolipoproteinemia (HP:0010981) | 1.82271459 |
| 152 | Postaxial hand polydactyly (HP:0001162) | 1.80978651 |
| 153 | Supraventricular arrhythmia (HP:0005115) | 1.80464455 |
| 154 | Myoglobinuria (HP:0002913) | 1.79828174 |
| 155 | Abnormality of serum amino acid levels (HP:0003112) | 1.78928185 |
| 156 | Tachypnea (HP:0002789) | 1.78927244 |
| 157 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.77796554 |
| 158 | Truncal ataxia (HP:0002078) | 1.77592583 |
| 159 | CNS demyelination (HP:0007305) | 1.77507558 |
| 160 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.76817116 |
| 161 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.74597672 |
| 162 | Brushfield spots (HP:0001088) | 1.73818353 |
| 163 | Abnormal pancreas size (HP:0012094) | 1.72577351 |
| 164 | Progressive external ophthalmoplegia (HP:0000590) | 1.72571781 |
| 165 | Proximal tubulopathy (HP:0000114) | 1.72383438 |
| 166 | Myotonia (HP:0002486) | 1.72105931 |
| 167 | Congenital stationary night blindness (HP:0007642) | 1.71104340 |
| 168 | Abnormal EKG (HP:0003115) | 1.70951418 |
| 169 | Ragged-red muscle fibers (HP:0003200) | 1.70293088 |
| 170 | Hyperglycinuria (HP:0003108) | 1.69294017 |
| 171 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.68340336 |
| 172 | Oculomotor apraxia (HP:0000657) | 1.68327783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 3.95723887 |
| 2 | FRK | 3.92970447 |
| 3 | MAP4K2 | 3.71348305 |
| 4 | CASK | 3.66965651 |
| 5 | STK16 | 2.91405061 |
| 6 | ARAF | 2.84372203 |
| 7 | MAP3K4 | 2.81710225 |
| 8 | MAP2K7 | 2.75462141 |
| 9 | MAPK13 | 2.71981586 |
| 10 | STK38L | 2.70429138 |
| 11 | NEK1 | 2.47052708 |
| 12 | CDK19 | 2.45250850 |
| 13 | MAP3K12 | 2.42937966 |
| 14 | NTRK3 | 2.12554948 |
| 15 | MINK1 | 2.10467336 |
| 16 | NME1 | 1.99295242 |
| 17 | MAPKAPK3 | 1.84356238 |
| 18 | MARK1 | 1.83899807 |
| 19 | MAP3K9 | 1.82756994 |
| 20 | TNIK | 1.81219053 |
| 21 | EPHA4 | 1.70339500 |
| 22 | PNCK | 1.67814431 |
| 23 | PRKD3 | 1.67465473 |
| 24 | MYLK | 1.64848000 |
| 25 | TSSK6 | 1.62364745 |
| 26 | PDK3 | 1.56816154 |
| 27 | PDK4 | 1.56816154 |
| 28 | OBSCN | 1.56426162 |
| 29 | GRK1 | 1.55683102 |
| 30 | PLK2 | 1.54773254 |
| 31 | BUB1 | 1.51554247 |
| 32 | ACVR1B | 1.50042128 |
| 33 | EEF2K | 1.49218047 |
| 34 | DAPK1 | 1.47776782 |
| 35 | AKT3 | 1.44747636 |
| 36 | MAP2K4 | 1.39378994 |
| 37 | WNK4 | 1.31072856 |
| 38 | LIMK1 | 1.26665011 |
| 39 | SIK3 | 1.26069494 |
| 40 | STK38 | 1.24492153 |
| 41 | CDK8 | 1.24404407 |
| 42 | CAMKK2 | 1.20565372 |
| 43 | DAPK2 | 1.19448643 |
| 44 | TGFBR1 | 1.18624906 |
| 45 | MAPKAPK5 | 1.17686887 |
| 46 | MAP2K6 | 1.15794815 |
| 47 | CSNK1G2 | 1.10578711 |
| 48 | UHMK1 | 1.10527327 |
| 49 | PHKG1 | 1.08698100 |
| 50 | PHKG2 | 1.08698100 |
| 51 | CSNK1G3 | 1.07342106 |
| 52 | BMPR1B | 1.05315104 |
| 53 | FGFR2 | 1.02875299 |
| 54 | CAMK2B | 1.02807564 |
| 55 | BRAF | 1.01694803 |
| 56 | CAMK1G | 1.01634542 |
| 57 | OXSR1 | 0.99062110 |
| 58 | PRPF4B | 0.98948831 |
| 59 | CAMK2A | 0.98031778 |
| 60 | KSR1 | 0.97369314 |
| 61 | ZAK | 0.95379624 |
| 62 | SRPK1 | 0.92906967 |
| 63 | IRAK1 | 0.91753512 |
| 64 | BRSK2 | 0.91538206 |
| 65 | BCKDK | 0.90554055 |
| 66 | ERBB3 | 0.88444819 |
| 67 | ADRBK2 | 0.82802139 |
| 68 | PRKCG | 0.82047952 |
| 69 | BCR | 0.81784386 |
| 70 | PINK1 | 0.81766713 |
| 71 | GRK5 | 0.80467678 |
| 72 | CDK5 | 0.78953796 |
| 73 | EPHA3 | 0.77149495 |
| 74 | NUAK1 | 0.75802900 |
| 75 | PKN1 | 0.75418246 |
| 76 | CAMK1 | 0.74566393 |
| 77 | BMPR2 | 0.74132366 |
| 78 | MUSK | 0.74097983 |
| 79 | NEK2 | 0.73801167 |
| 80 | RAF1 | 0.70778660 |
| 81 | PAK3 | 0.69328426 |
| 82 | AKT2 | 0.68945035 |
| 83 | CDK18 | 0.68797911 |
| 84 | CDK14 | 0.67529198 |
| 85 | CAMK2D | 0.66814619 |
| 86 | PRKAA1 | 0.65921487 |
| 87 | NTRK2 | 0.65495437 |
| 88 | SGK494 | 0.64837270 |
| 89 | SGK223 | 0.64837270 |
| 90 | TNK2 | 0.64602984 |
| 91 | PIK3CA | 0.63656968 |
| 92 | PRKAA2 | 0.62346249 |
| 93 | CDK11A | 0.61667547 |
| 94 | DYRK1A | 0.60879806 |
| 95 | RPS6KB1 | 0.59984653 |
| 96 | CSNK1A1 | 0.58553811 |
| 97 | CDK15 | 0.58109578 |
| 98 | ADRBK1 | 0.57940046 |
| 99 | CSNK1A1L | 0.57523506 |
| 100 | CSNK1G1 | 0.57325805 |
| 101 | RPS6KA4 | 0.57078064 |
| 102 | PRKCI | 0.57037138 |
| 103 | PRKCH | 0.55123436 |
| 104 | GRK7 | 0.54758110 |
| 105 | DYRK3 | 0.53533462 |
| 106 | WNK3 | 0.51890285 |
| 107 | MAP2K1 | 0.51859956 |
| 108 | SGK2 | 0.50768767 |
| 109 | IRAK2 | 0.50369138 |
| 110 | MARK2 | 0.49624504 |
| 111 | PRKCE | 0.48680172 |
| 112 | CDK3 | 0.47852588 |
| 113 | VRK1 | 0.47011174 |
| 114 | DYRK2 | 0.46726730 |
| 115 | GRK6 | 0.46054227 |
| 116 | ROCK1 | 0.44948223 |
| 117 | BRD4 | 0.44460872 |
| 118 | ROCK2 | 0.44442730 |
| 119 | WNK1 | 0.44017140 |
| 120 | MKNK1 | 0.42922785 |
| 121 | CAMK2G | 0.42882162 |
| 122 | EIF2AK3 | 0.42630850 |
| 123 | MST4 | 0.42627967 |
| 124 | NLK | 0.42287765 |
| 125 | MAP3K13 | 0.42201264 |
| 126 | PIK3CG | 0.42023078 |
| 127 | PRKACA | 0.41890974 |
| 128 | MAPK12 | 0.40914346 |
| 129 | MKNK2 | 0.40788908 |
| 130 | PTK2B | 0.39164436 |
| 131 | INSRR | 0.39019645 |
| 132 | FER | 0.38839712 |
| 133 | CSNK1D | 0.38794902 |
| 134 | PDK2 | 0.38677652 |
| 135 | STK3 | 0.37909421 |
| 136 | RPS6KA5 | 0.37574163 |
| 137 | TRPM7 | 0.37500820 |
| 138 | STK39 | 0.36299962 |
| 139 | PLK3 | 0.34667781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.58218752 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.33622580 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.98269161 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.42097301 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.22612583 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.92997723 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.92361497 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.69991326 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.62138757 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.53961996 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51372667 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.24840783 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.17855468 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.14782190 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.12228964 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.95105610 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.90065348 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.89031074 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88189756 |
| 20 | Proteasome_Homo sapiens_hsa03050 | 1.86198666 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.81987971 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65029362 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58388642 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56811848 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52721867 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51341961 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50846709 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50419914 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46831591 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43843535 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41230159 |
| 32 | Taste transduction_Homo sapiens_hsa04742 | 1.40069333 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38422975 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34766684 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.34286528 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.33161525 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30306834 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29662214 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26471262 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.25506517 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.24831145 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21689156 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.19131272 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18825090 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.16382532 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15432013 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.13379212 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12810954 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.12542452 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12400478 |
| 51 | Protein export_Homo sapiens_hsa03060 | 1.12182954 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.11151001 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10910781 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09587508 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09571048 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 1.08254407 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 1.07170900 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06616881 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04172594 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 1.00965695 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99844356 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.96507521 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.95800003 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93666503 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93512278 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93108814 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92925029 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92218721 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91184885 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89705226 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89337335 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88538862 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88435210 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88364146 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87662984 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83705485 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.82578055 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81427645 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80885369 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80411892 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78582260 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77166981 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76986784 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.76832183 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75627193 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74543084 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74107528 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73361984 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73245600 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72298749 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.67935519 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67916267 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66836442 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.65839917 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64002824 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59930192 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57352818 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53316575 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52587534 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52536882 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52012058 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50852087 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49424994 |
| 104 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48267274 |
| 105 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.47861694 |
| 106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47788834 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47713775 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47185072 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46688212 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45359518 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44933116 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.44819774 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44036220 |
| 114 | Spliceosome_Homo sapiens_hsa03040 | 0.43950475 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43941925 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.43482336 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43413239 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43403665 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43217833 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42506732 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39146007 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39073744 |
| 123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.38384019 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37659367 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37151554 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34888467 |
| 127 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33921917 |
| 128 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33131861 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32847147 |
| 130 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32140693 |
| 131 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.31103388 |
| 132 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30368671 |
| 133 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28472933 |
| 134 | RNA degradation_Homo sapiens_hsa03018 | 0.28028610 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25875770 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25078253 |
| 137 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.24881120 |
| 138 | Basal transcription factors_Homo sapiens_hsa03022 | 0.24579406 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.22853252 |
| 140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22836237 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.19393959 |
| 142 | RNA transport_Homo sapiens_hsa03013 | 0.19363229 |
| 143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18825531 |
| 144 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17978373 |
| 145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.17812848 |
| 146 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.17706722 |

